US 9561245
Combination treatments for melanoma
granted A61KA61K31/404A61K31/437
Quick answer
US patent 9561245 (Combination treatments for melanoma) held by The Board of Regents of the University of Texas System expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/404, A61K31/437, A61K31/506, A61K31/585